A data-informed mathematical model of microglial cell dynamics during ischemic stroke in the middle cerebral artery
Neuroinflammation immediately follows the onset of ischemic stroke in the middle cerebral artery. During this process, microglial cells are activated in and recruited to the penumbra. Microglial cells can be activated into two different phenotypes: M1, which can worsen brain injury; or M2, which can...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Neuroinflammation immediately follows the onset of ischemic stroke in the
middle cerebral artery. During this process, microglial cells are activated in
and recruited to the penumbra. Microglial cells can be activated into two
different phenotypes: M1, which can worsen brain injury; or M2, which can aid
in long-term recovery. In this study, we contribute a summary of experimental
data on microglial cell counts in the penumbra following ischemic stroke
induced by middle cerebral artery occlusion (MCAO) in mice and compile
available data sets into a single set suitable for time series analysis.
Further, we formulate a mathematical model of microglial cells in the penumbra
during ischemic stroke due to MCAO. Through use of global sensitivity analysis
and Markov Chain Monte Carlo (MCMC)-based parameter estimation, we analyze the
effects of the model parameters on the number of M1 and M2 cells in the
penumbra and fit identifiable parameters to the compiled experimental data set.
We utilize results from MCMC parameter estimation to ascertain uncertainty
bounds and forward predictions for the number of M1 and M2 microglial cells
over time. Results demonstrate the significance of parameters related to M1 and
M2 activation on the number of M1 and M2 microglial cells. Simulations further
suggest that potential outliers in the observed data may be omitted and
forecast predictions suggest a lingering inflammatory response. |
---|---|
DOI: | 10.48550/arxiv.2403.15284 |